Researchers specializing in medical technology to help injured troops recently convened in Georgia for the second annual Augusta Research Symposium on Advances in Warrior Care. One of the symposium’s major topics was traumatic brain injury.
Brain damage is all too common among soldiers deployed in high conflict areas. Victims are not only those on the front lines, but any person serving in a war zone, including support personnel who can become targets of improvised explosive devices.
According to a former Army vice chief of staff, advances in treatment for traumatic brain injury for soldiers are not coming as quickly as they need to and are not as widely available as they should be. He emphasizes particularly that there’s a need for researchers and clinicians to collaborate on making advancements and to share data.
While the issue of brain injury is significant in the context of military conflict, the general notes that 1.7 million civilians are treated for brain damage annually. The causes can be myriad, from brain injuries resulting from car accidents, falls, sports and even negligent medical practices.
Recovery from traumatic brain injuries also tends to be an uphill battle. A patient may suffer from concussion, hearing loss, memory loss and blindness. Rehabilitation can take months or even years, and many victims are left with a permanent disability and a lifetime of pain management.
Anyone who suffers traumatic brain injury as a result of another’s negligent or careless conduct should know that legal remedies are available. With the help of an experienced personal injury attorney, a victim can seek damages from the at-fault party. A judge or jury can award damages to compensate the plaintiff for medical expenses, loss of earning capacity, pain and suffering.
A monetary award cannot provide a cure for brain injury. It can ease the financial burden a victim faces through no fault of their own.
Source: The Augusta Chronicle, “Private sector will lead in breakthroughs in brain disorders, general says,” Tom Corwin, Oct. 30, 2012